Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease

Documenti analoghi

• Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
  di: Jennifer Longoria, et al.
  Pubblicazione: (2024)
• User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease
  di: Christina M. Abrams, et al.
  Pubblicazione: (2025)
• Statewide Academic Performance of High School Students With Sickle Cell Disease
  di: Andrew M. Heitzer, et al.
  Pubblicazione: (2025)
• Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
  di: Aimee K. Hildenbrand, et al.
  Pubblicazione: (2026)
• Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
  di: Jill S. Menell, et al.
  Pubblicazione: (2025)